Drug Pipeline

GS-5423 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 2
2
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07054931 Combination Vaccination and Broadly Neutralising Antibody Therapy in HIV HIV Recruiting
NCT05729568 A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir… HIV-1 Infection Active, Not Recruiting
Phase 1/2
NCT06071767 Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults… HIV-1-infection Recruiting
Phase 1
NCT05612178 A Study to Evaluate the Safety and Effects of Repeated Doses of 3BNC117-LS and 10-1074-LS… HIV-1 Active, Not Recruiting
Sponsors Running GS-5423 Trials
Get alerts when GS-5423 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free